Table 7.
Interval | Meloxicam IV | Placebo |
---|---|---|
0‒24 hrs | ||
n | 282 | 96 |
Mean ± SD | 22.1 ± 22.75 | 31.1 ± 30.87 |
P value | 0.0032 | |
24‒48 hrs | ||
n | 275 | 93 |
Mean ± SD | 11.7 ± 18.67 | 15.7 ± 23.92 |
P value | 0.0362 | |
48‒72 hrs | ||
n | 126 | 41 |
Mean ± SD | 5.3 ± 11.13 | 8.6 ± 22.80 |
P value | 0.2178 | |
0‒48 hrs | ||
n | 282 | 96 |
Mean ± SD | 33.5 ± 37.05 | 46.3 ± 46.51 |
P value | 0.0032 | |
0‒72 hrs | ||
n | 282 | 96 |
Mean ± SD | 35.9 ± 40.86 | 50.0 ± 55.59 |
P value | 0.0037 | |
During treatment | ||
n | 282 | 96 |
Mean ± SD | 36.8 ± 42.69 | 50.3 ± 55.74 |
P value | 0.0081 |
Note: *Intravenous morphine equivalent dose (mg).
Abbreviations: IV, intravenous; SD, standard deviation.